相似文献
1
Year in review 2007: Critical Care--shock.
Crit Care. 2008;12(5):227. doi: 10.1186/cc6949. Epub 2008 Oct 14.
2
Year in review 2006: Critical Care--Multiple organ failure, sepsis, and shock.
Crit Care. 2007;11(4):221. doi: 10.1186/cc5938.
3
Year in review 2009: Critical Care--shock.
Crit Care. 2010;14(6):239. doi: 10.1186/cc9261. Epub 2010 Nov 5.
4
Year in review 2013: Critical Care--sepsis.
Crit Care. 2014 Oct 15;18(5):578. doi: 10.1186/s13054-014-0578-x.
5
Critical care in the emergency department: shock and circulatory support.
Emerg Med J. 2005 Jan;22(1):17-21. doi: 10.1136/emj.2003.012450.
6
Microcirculatory responses to hypovolemic shock.
J Trauma. 2011 Dec;71(6):1779-88. doi: 10.1097/TA.0b013e31823a05b5.
7
Year in review 2007: Critical Care--multiple organ failure and sepsis.
Crit Care. 2008;12(5):228. doi: 10.1186/cc6950. Epub 2008 Oct 14.
8
Physiological modelling of agitation-sedation dynamics.
Med Eng Phys. 2006 Jan;28(1):49-59. doi: 10.1016/j.medengphy.2005.03.005.
9
The importance of the peripheral circulation in critical illnesses.
Intensive Care Med. 2001 Sep;27(9):1446-58. doi: 10.1007/s001340101034.
10
[New developments in clinical therapy of shock].
Chirurg. 1995 Nov;66(11):1040-9.
引用本文的文献
1
New strategies for Alzheimer's disease and cognitive impairment.
Oxid Med Cell Longev. 2009 Nov-Dec;2(5):279-89. doi: 10.4161/oxim.2.5.9990.
2
Oxidative stress: Biomarkers and novel therapeutic pathways.
Exp Gerontol. 2010 Mar;45(3):217-34. doi: 10.1016/j.exger.2010.01.004. Epub 2010 Jan 11.
3
Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.
ScientificWorldJournal. 2009 Oct 2;9:1072-104. doi: 10.1100/tsw.2009.121.
4
The vitamin nicotinamide: translating nutrition into clinical care.
Molecules. 2009 Sep 9;14(9):3446-85. doi: 10.3390/molecules14093446.
本文引用的文献
1
Surviving blood loss using hydrogen sulfide.
J Trauma. 2008 Jul;65(1):183-8. doi: 10.1097/TA.0b013e3181507579.
2
Erythropoietin during porcine aortic balloon occlusion-induced ischemia/reperfusion injury.
Crit Care Med. 2008 Jul;36(7):2143-50. doi: 10.1097/CCM.0b013e31817d7912.
3
Vasopressin versus norepinephrine infusion in patients with septic shock.
N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373.
4
Nitric oxide, leukocytes and microvascular permeability: causality or bystanders?
Crit Care. 2008;12(1):104. doi: 10.1186/cc6214. Epub 2008 Jan 16.
5
Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?
Crit Care. 2007;11(6):178. doi: 10.1186/cc6171.
6
The relationship between gastric emptying, plasma cholecystokinin, and peptide YY in critically ill patients.
Crit Care. 2007;11(6):R132. doi: 10.1186/cc6205.
7
Causes of metabolic acidosis in canine hemorrhagic shock: role of unmeasured ions.
Crit Care. 2007;11(6):R130. doi: 10.1186/cc6200.
8
Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow.
Crit Care. 2007;11(6):R129. doi: 10.1186/cc6197.
9
Discordance between microvascular permeability and leukocyte dynamics in septic inducible nitric oxide synthase deficient mice.
Crit Care. 2007;11(6):R125. doi: 10.1186/cc6190.
10
Improving the ability to predict mortality among burn patients.
Burns. 2008 May;34(3):320-7. doi: 10.1016/j.burns.2007.06.003. Epub 2007 Sep 14.
Zotero 插件